Both in Pharmaceuticals

Karyopharm Therapeutics vs GeoVax Labs, Inc. New

Over the past year KPTI returned −98.7% and GOVX returned −98.8%; their daily moves had a correlation of 0.00.

KPTI −98.7% GOVX −98.8%Growth of $1, one year, split-adjusted
MetricKPTIGOVX
Price$0.0729$0.1680
Market cap$1.7M$1.5M
Today−17.44%+2.38%
1 month−88.8%−41.8%
6 months−99.2%−89.8%
Year to date−99.0%−96.1%
1 year−98.8%−98.8%
Revenue growth (YoY)−11.9%−100.0%
Gross margin96.8%—
Net margin−200.5%—
P/E (TTM)——
Price / sales0.0×—
Net cash-$184.8M$3.1M
Dividend yield——
Volatility (60d)413.8%77.0%
Short % of float34.2%3.0%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).

KPTI vs GOVX: Karyopharm Therapeutics vs GeoVax Labs, Inc. New Stock Comparison | Gainbot